Search results for:
raNITIdine
raNITIdine
| Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
| Zantac |
SOLUTION, INJECTABLE |
25 mg/mL |
|
|
|
|
| Zantac |
SYRUP, ORAL |
15 mg/mL |
|
|
|
|
| Zantac |
TABLET, ORAL |
75 mg, 150 mg, 300 mg |
|
|
|
|
Last updated: Nov. 26, 2025
raNITIdine (Zantac)
famotidine (Pepcid)
Pediatric dosing of famotidine:
If H2 blocker prescribed with PPO, discontinue H2 blocker after 48 hours. Exception if GI physician -- check with physician that H2 blocker is not being used for a non-GI use prior to discontinuing.
Automatic IV to PO conversion per IV to oral conversion guidelines. IV to PO Conversion Guidelines
Updated: 3 April 2020, 28 April 2020